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Abstract 
The term “Ehlers-Danlos syndrome” (EDS) groups 
together an increasing number of heritable connective 
tissue disorders mainly featuring joint hypermobility and 
related complications, dermal dysplasia with abnormal 
skin texture and repair, and variable range of the hollow 
organ and vascular dysfunctions. Although the nervous 
system is not considered a primary target of the 
underlying molecular defect, recently, increasing 
attention has been posed on neurological 
manifestations of EDSs, such as musculoskeletal pain, 
fatigue, headache, muscle weakness and paresthesias. 
Here, a comprehensive overview of neurological 
findings of these conditions is presented primarily 
intended for the clinical neurologist. Features are 
organized under various subheadings, including pain, 
fatigue, headache, stroke and cerebrovascular disease, 
brain and spine structural anomalies, epilepsy, muscular 
findings, neuropathy and developmental features. The 
emerging picture defines a wide spectrum of 
neurological manifestations that are unexpectedly 
common and potentially disabling. Their evaluation and 
correct interpretation by the clinical neurologist is 
crucial for avoiding superfluous investigations, wrong 
therapies, and inappropriate referral. A set of basic tools 
for patient’s recognition is offered for raising awareness 
among neurologists on this underdiagnosed group of 
hereditary disorders. 
Introduction 
Since the first description in the medical literature,1,2 
the definition of Ehlers-Danlos syndrome (EDS) is 
significantly changed and actually refers to an 
expanding spectrum of heritable connective tissue 
disorders sharing the variable triad of (i) generalized 
joint hypermobility and related osteoarticular 
complications, (ii) dermal dysplasia extending from 
minor changes of skin texture to clinically relevant 
skin fragility and defective scarring, and (iii) vascular 
and internal organ fragility with proneness to 
traumatic injuries and spontaneous ruptures, 
dissections and prolapses (Figure 1). Nosology of EDS 
mirrors its heterogeneous clinical manifestations and, 
at present, comprises six major forms or variants (i.e., 
classic, hypermobility, vascular, kyphoscoliotic, 
arthrochalasis and dermatosparaxis types)3 (Table 1), 
as well as a growing list of apparently rarer subtypes 
(Table 2). At present, the clinical suspect of many EDS 
variants, can be confirmed by specific laboratory 
investigations, particularly molecular testing.4 
Nevertheless, the EDS hypermobility type (EDS-HT), 
which is one of the most common variants, is still a 
clinical diagnosis based on subtle and likely unspecific 
features, and shows a nearly complete phenotypic 
overlap with the joint hypermobility syndrome (JHS) 
(Table 3), a heritable rheumatologic condition defined 
by the Brighton criteria.5-7 The question whether EDS-
HT and JHS are also identical at the molecular level is 
still a matter of debate.8 This implies that while a 
group of patients receive a stringent laboratory 
confirmation of rarer, but well-defined EDS variants,  
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Figure 1. Examples of cutaneous and articular manifestations of Ehlers-Danlos syndrome (EDS). Papyraceous scars at knees 
in a adult man (A) and woman (B) with classic EDS. Various degrees of skin hyperextensibility (C, D). Extensive easy 
bruising due to capillary fragility in a adult (E) and child (F). Joint hypermobility at fingers (G). Genu recurvatum (H) 
 
all others, who fall within the blurring spectrum of 
JHS/EDS-HT, often escape practitioner’s attention 
and sometimes develop disabling, but potentially 
preventable complications. In line with this, the 
presumed cumulative frequency of 1 in 5000 
individuals in the general population for EDS9 is 
likely an underestimation and the real prevalence of a 
single more common variants may be much higher as 
recently proposed for JHS.10 
Recurrent muscle cramps have been reported in EDS by 
Beighton and Horan since the late sixties.11 After this 
early paper, which actually focused on orthopedic 
aspects of EDS, many other reports (reviewed in the 
following sections) have highlighted a possibly 
prominent involvement of the nervous system in this 
condition. Nevertheless, most works describe single 
patients or small case series, contributing to the lack of 
awareness of neurological manifestations of EDS. In 
2009, Voermans et al., for the first time, illustrate their 
findings in 40 patients with various forms of EDS and 
demonstrate a subtle, but significant neuromuscular 
involvement in this condition.12 
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Table 1. Villefranche criteria for the six major subtypes of Ehlers-Danlos syndrome 
Common 
variant Inheritance 
Causative 
gene(s) Major criteria Minor criteria 
Classic AD COL5A1, 
COL5A2 
Skin hyperextensibility 
Widened atrophic scars 
Joint hypermobility 
Smooth, velvety skin 
Molluscoid pseudotumors 
Subcutaneous spheroids 
Complications of joint hypermobility 
Muscle hypotonia, motor delay 
Easy bruising 
Manifestations of tissue extensibility and 
fragility 
Surgical complications 
Positive family history 
Hypermobility AD Mostly unknown 
 
Hyperextensible and/or 
Smooth, velvety skin 
Generalized joint 
hypermobility 
Recurring joint dislocations 
Chronic joint/limb pain 
Positive family history 
Vascular AD COL3A1 Thin, translucent skin 
Arterial/intestinal/uterine 
fragility or rupture 
Extensive bruising 
Characteristic facial 
appearance 
Acrogeria 
Hypermobility of small joints 
Tendon and muscle rupture 
Talipes equinovarus 
Early-onset varicose veins 
Arteriovenous, carotid-cavernous sinus 
fistula 
Pneumothorax/pneumohemothorax 
Gingival recessions 
Positive family history, sudden death in 
a close relative 
Kyphoscoliotic AR PLOD1 Generalized joint 
hypermobility 
Congenital hypotonia 
Congenital and progressive 
scoliosis 
Scleral fragility and rupture 
of the ocular globe 
Tissue fragility, including atrophic scars 
Easy bruising 
Arterial rupture 
Marfanoid habitus 
Microcornea 
Osteopenia/porosis 
Positive family history 
Arthrochalasis AD COL1A1, 
COL1A2 
Generalized joint 
hypermobility with 
recurrent subluxations 
Congenital bilateral hip 
dislocation 
Skin hyperextensibility 
Tissue fragility, including atrophic scars 
Easy bruising 
Hypotonia 
Kyphoscoliosis 
Osteopenia/porosis 
Dermatosparaxis AR ADAMTS2 Severe skin fragility 
Sagging, redundant skin 
Soft, doughy skin texture 
Easy bruising 
Premature rupture of fetal membranes 
Large hernias (umbilical, inguinal) 
AD: Autosomal dominant; AR: Autosomal recessive; EDS: Ehlers-Danlos syndrome. No clear indication for using these criteria in the 
establishment of a firm clinical suspect of a specific EDS subtype is specified. However, the presence of at least 1 major and 1 minor criteria is 
usually necessary for proceeding in molecular confirmation of EDS subtypes with a known, prevalent molecular cause. The presence of at least 
two major criteria is strongly indicative for a definite diagnosis of the specific EDS subtype. Adapted from Beighton et al.3 
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Table 2. Rare variants of Ehlers-Danlos syndrome with currently unavailable clinical diagnostic criteria 
Rare variant Inheritance Gene(s) 
Association with 21 α-hydroxylase deficiency AR TNXB, CYP21B 
Association with Gilles de la Tourette syndrome AD HDC 
Association with parodontitis AD Unknown 
Association with periventricular heterotopia XLD FLNA 
Brittle cornea syndrome type 1 AR ZNF469 
Brittle cornea syndrome type 2 AR PRDM5 
Cardiac-valvular AR COL1A2 
Classic with arterial rupture AD COL1A1 
Ehlers-Danlos syndrome/osteogenesis imperfecta overlap AD COL1A1, COL1A2 
Ehlers-Danlos syndrome-like due to 6q27 deletion Sporadic/AD Not applicable 
Kyphoscoliotic with myopathy and deafness AR FKBP14 
Musculocontractural, type 1 AR CHST14 
Musculocontractural, type 2 AR DSE 
Overlap phenotype due to COL3A1/COL5A2/MSTN haploinsufficiency AD COL3A1, COL5A2, MSTN (deletion) 
Progeroid AR B4GALT7 
Spondylocheirodysplasia AR SLC39A13 
Tenascin X-deficient AR, AD (?) TNXB 
AD: Autosomal dominant; AR: Autosomal recessive; XLD: X-linked dominant; EDS: Ehlers-Danlos syndrome 
 
Table 3. Brighton criteria for the joint hypermobility syndrome 
Criteria 
Major criteria 
Beighton score ≥ 4/9 
Arthralgia for > 3 months in > 4 joints 
Minor criteria 
Beighton score 1-3  
Arthralgia in 1-3 joints 
History of joint dislocations 
Soft tissue lesions > 3 
Marfan-like habitus 
Skin striae, hyperextensibility, or scarring 
Downslanting palpebral fissures, lid laxity, myopia 
History of varicose veins, hernia, visceral prolapse 
Agreement: Both major, or 1 major and 2 minor, or 4 minor criteria. Criteria major 1 and minor 1 are mutually exclusive as 
are major 2 and minor 2. 
Source: Grahame et al. and subsequent modifications (see, for example, Tinkle et al.) 
 
A recent review, primarily intended for a 
readership of child neurologists, emphasizes a 
heterogeneous and potentially disabling neurological 
involvement in EDS with a wide range of apparently 
low-frequency, but possibly subtype-specific 
anomalies of the nervous system.13 In addition, at least 
for JHS/EDS-HT, musculoskeletal pain, fatigue and 
headache represent the master contributors to 
patients’ referral to the practitioner and quality of life 
deterioration.14 Now, it is clear enough that the 
understanding of the extent of nervous system 
involvement and of its underlying pathogenic 
processes represents a nodal point for better assessing 
EDS patients and developing more efficient 
rehabilitation and prevention strategies. 
In this paper, we review pertinent literature 
reporting a seemingly increased rate of neurological 
features in EDS. Our aim was to offer a practical 
reference to the clinical neurologist in considering this 
condition in subjects with an apparently primary 
neurological condition, as well as to those taking part 
to the multidisciplinary team involved in the 
management of EDS patients. 
Search Methods 
This work was intended as a narrative review 
summarizing actual evidence on nervous system 
involvement in EDS. A PubMed search was carried 
out matching the terms “EDS” OR “hypermobility 
syndrome” with the following: central nervous 
system, brain, myelum, spine, stroke, epilepsy, 
muscle, myopathy, peripheral nerve(s), 
polyneuropathy, (peripheral) nervous system, and 
nerve. Papers were selected when reporting EDS/JHS 
patients with neurological manifestations. The 
reference list of selected papers was further searched 
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for additional reports. Our findings were reported in 
the following paragraphs. 
Pain 
Pain is now accepted as a common and potentially 
disabling feature of various forms of EDS, especially 
JHS/EDS-HT.14 This is testified by the inclusion of 
chronic musculoskeletal pain as a major item in the 
Brighton criteria for JHS5 and minor feature in the 
Villefranche criteria for selected EDS subtypes.3 
Conversely, in the early EDS literature, pain was 
recognized as a marginal finding, usually occurring 
acutely due to (sub) luxations, spontaneous rupture of 
vessels15 and internal organs,16 or recurring in relation 
to piezogenic pedal papules17 or gynecologic/obstetric 
complications18 In 1994, Lumley et al. first pointed out 
a possible role of chronic pain in the quality of life of 
EDS patients by studying psychosocial functioning in 
48 subjects with various forms of EDS.19 Furthermore, 
the repeated evidence of resistance to local anesthetics 
in both EDS-HT20 and JHS21 suggests a more complex 
effect on pain perception and modulation processes in 
EDS, since the very end of the last century. Scientific 
awareness on the clinical significance of chronic pain 
in EDS increased in 2010, when Voermans et al. 
published the results of their questionnaire study on 
273 patients with various forms of EDS (mainly, 
classic, hypermobility and vascular types) and found 
pain as common, severe, and associated with 
functional impairment. Interestingly, pain seemed 
more severe in EDS-HT than classic and vascular 
types, and pain severity was correlated with 
hypermobility, dislocations and previous surgery.22 
This preliminary observation prompted the same 
research group to state that pain and fatigue are 
possible important determinants of disability of EDS-
HT.23 On a clinical perspective, chronic-recurrent joint 
pain is the most common presentation of pain in 
JHS/EDS-HT, which is reflected by the applicable 
diagnostic criteria.3,5 Additional manifestations of 
musculoskeletal pain in JHS/EDS-HT and perhaps 
other EDS subtypes include muscle cramps,11 
fibromyalgia24,25 and compression/peripheral 
neuropathies.26,27 Pain is not limited to the 
musculoskeletal system and often presents with 
visceral involvement, in the form of various 
gastrointestinal chronic and recurrent symptoms,28 as 
well as dyspareunia, vulvodinia and 
dysmenorrhea.29,30 Headache is also common in EDS31 
and is discussed in a separate section. The study of the 
natural history of JHS/EDS-HT tells us that pain is a 
changing feature in EDS and its functional 
consequences are influenced by the adaptation 
strategies that the various structures of the affected 
individual develop, as a whole, to face repetitive pain 
perception.14 Accordingly and following previous 
postulations,14 a recent work by Rombaut et al. 
demonstrates the presence of hyperalgesia in EDS-
HT.32 This finding may represent a preliminary proof 
for the action of central sensitization processes in 
those EDS patients who develop the most severe 
disabilities associated to pain. 
Fatigue 
Though largely ignored in the past, severe fatigue is 
now considered a common accompanying feature of 
EDS, particularly EDS-HT, as it is reported in up to 
84% of the patients.33 Similar results are obtained by 
other research groups.34,35 More specifically, the 
frequency (and, perhaps, severity) of fatigue is 
influenced by age with a rate of 28% in the first 
decade of life to 90% in adults over 40 years of age.35 
In JHS/EDS-HT, the impact of fatigue on daily life is 
often equal or more dramatic than the impact of 
pain;33 a fact that underscores the importance of 
fatigue for both assessment and treatment planning in 
these patients. A complex presentation of fatigue 
resembling chronic fatigue syndrome according to 
Fukuda et al.36 is reported in most adults with 
JHS/EDS-HT.37 
Some possible contributors to fatigue-related 
disability have been investigated in EDS and include 
sleep disturbances, concentration problems, social 
functioning, self-efficacy concerning fatigue, and pain 
severity.33 A few experimental studies demonstrate 
that fatigue associates with muscle weakness,38,39 
worsens with exercise40 and affects gait pattern.41 
Recently, dysautonomia was recognized as one of the 
most relevant pathogenic factors influencing fatigue 
onset and evolution. This feature, mostly studied in 
JHS/EDS-HT, often presents with orthostatic 
tachycardia syndrome42 and/or orthostatic 
intolerance, and seems to relate to increased 
sympathetic activity at rest and reduced sympathetic 
reactivity to stimuli.43 
Headache and Head Pain 
In 1996, Spranger et al. first report headache, drop 
attacks and white matter abnormalities in a 37-year-
old woman with EDS with parodontitis.44 1 year later, 
a larger study on 51 individuals with different forms 
of EDS (including 13 patients with classic type, 28 
with EDS-HT, 1 with JHS, 7 with vascular type, and 2 
with unclassified type) showed that neck pain and 
headache is present in 30-40% of cases.31 A subsequent 
case series reports nine EDS patients presenting with 
various forms of headache, including (i) migraine 
with aura, (ii) migraine without aura, (iii) tension-type 
headache, (iv) a combination of tension-type headache 
and migraine, and (v) post-traumatic headache.45 
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Additional works on small case series confirm the 
high prevalence of headache in JHS/EDS-HT.34,46 
More specifically, Bendik et al. show that migraine 
(with or without aura) is approximately three times 
more common among a group of 28 women with 
JHS/EDS-HT compared with 232 controls with a 
cumulative frequency of 75% (3/4).47 In a 36-year-old 
woman with orthostatic headache and idiopathic 
intracranial hypertension, the diagnosis of JHS was 
reached 2 years later the onset of head pain.48 This 
patient displayed increased IGF-1 plasma levels and 
the authors speculated on a possible pathogenic link. 
Head pain is not limited to headache in EDS. In a 
cohort of 31 EDS patients (including 16 with EDS-HT, 
nine with classic EDS and six with vascular EDS), De 
Coster et al. demonstrated temporomandibular joint 
dysfunction in 100% of the cases, unilateral myofascial 
pain (i.e., temple headache) in 83%, and unilateral and 
bilateral temporomoandibular joint pain in 28% and 
51% of the patients, respectively.49 
While many EDS patients may develop chronic or 
recurrent headache, individuals with EDS types with 
vascular fragility (e.g., vascular EDS, classic EDS with 
arterial rupture and kyphoscoliotic EDS) are at 
increased risk of sudden headache secondary to acute 
cerebrovascular disease. In particular, acute headache 
may occur together with ophthalmoplegia or tinnitus 
due to spontaneous, direct caveronous-carotid 
fistulain this EDS type.50,51 Additional observations 
point out possible associations between localized or 
generalized joint hypermobility and specific subsets of 
primary and secondary types of headache, including 
new daily persistent headache52 and headache 
attributed to spontaneous (idiopathic) cerebrospinal 
fluid leakage.53,54 Cervical spine 
hypermobility/dysfunction is also anecdotally 
considered a predisposing factor for cervicogenic 
headache55,56 and neck-tongue syndrome.57-59 In line 
with this, Di Palma and Cronin report a 27-year-old 
woman with classic EDS with a long-lasting pulsating 
headache associated with C2 dislocation.60 
Stroke and Cerebrovascular Disease 
Most reports on stroke and cerebrovascular disease in 
EDS concern vascular EDS and include intracranial 
aneurysms, subarachnoid hemorrhage, spontaneous 
arterial dissection and cavernous sinus fistula. In 
patients with classic EDS, aneurysms occasionally 
occur, whereas other vascular abnormalities are rare. 
In fact, the presence of stroke in patients with 
cutaneous features of classic EDS should prompt to 
molecular investigation for the classic variant with 
arterial rupture due to mutations in COL1A1. 
In 1990, Schievink et al. reported two vascular EDS 
patients, one with a spontaneous internal carotid 
artery dissection and one with an aneurysmal 
subarachnoid hemorrhage and multiple aortic 
dissections.61 Both patients were deficient in collagen 
Type III, analyzed in cultured skin fibroblasts. 
Subsequently, the same author reported a 20-year-old 
woman with vascular EDS, who presented with a 
spontaneous carotid-cavernous fistulae and a cervical 
artery dissection.62 The clinical features of 16 
previously published cases of spontaneous carotid-
cavernous fistulae were also reviewed.62 Since 
collagen Type III deficiency plays a role in the 
pathogenesis of intracranial saccular aneurysms, it is 
likely to be involved in the pathogenesis of carotid 
cavernous fistulas and dissections of the cervical 
arteries.61 In 1995, North et al. studied the 
cerebrovascular complications in a cohort of 202 
patients with vascular EDS.63 19 patients had 
cerebrovascular complications, including intracranial 
aneurysms with secondary hemorrhage, spontaneous 
carotid-cavernous sinus fistula and cervical artery 
dissection. The aneurysms typically develop in the 
cavernous sinus or directly adjacent to it, and bilateral 
and recurrent carotid aneurysms have also been 
reported.64-68 Aneurysmal rupture can occur 
spontaneously or during vigorous activity.61,63 A 
carotid-cavernous fistula can develop after minor 
head trauma, but most occur spontaneously, in many 
cases after a ruptured internal carotid artery 
aneurysm within the cavernous sinus.62 These carotid-
cavernous fistula often present with exophthalmos, 
chemosis, pain, opthalmoplegia and bruits, which 
result from their high blood flow which allows 
pressurized arterial blood to connect directly to the 
cavernous sinus resulting in venous hypertension and 
reversal of venous drainage.69 
Although uncommon, vascular EDS is a potential 
cause of stroke in young people.70-72 In typical cases, 
the disorder is readily identifiable by clinical 
inspection and targeted molecular testing. However, 
the phenotypic variability of vascular EDS could lead 
to under diagnosis, especially in an emergency 
setting.71 Hence, a full clinical history and examination 
and a complete familial history should be emphasized 
as often only the combination of all these data will 
raise suspicion of vascular EDS. This is crucial since 
the diagnosis has important implications for acute and 
long-term management and, potentially, for other 
family members.71 
In vascular EDS, the traditional approach has been 
to treat such complications conservatively unless they 
are life-threatening. Recent reports challenge this 
treatment paradigm.73 In a randomized study, 
treatment with the beta-blocker Celiprolol was shown to 
be associated with a three-fold decrease in arterial 
rupture in vascular EDS.74 Novel approaches using 
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endovascular therapy with coil embolization have 
shown good results in the treatment of ruptured 
pseudoaneurysms and carotid-cavernous fistulas.69,73 
Nevertheless, complications are frequently reported. 
Anticoagulation therapy may result in increased 
bruising or bleeding and should be used with 
caution.63,75 Because conventional angiography may 
exacerbate severe complications, non-invasive magnetic 
resonance angiography is the investigation of choice. 
Brain and Spine Structural Anomalies 
Brain magnetic resonance imaging (MRI) is usually 
unremarkable for major structural anomalies in EDS. 
Therefore, with the exception of acute presentations 
with the suspect of cerebrovascular disease, such an 
investigation usually does not take place in the 
baseline assessment of EDS patients. Nevertheless, the 
presence of clear-cut X-linked dominant transmission 
and/or the coexistence of seizures should elicit the 
exclusion of the rare form of EDS with periventricular 
heterotopias (Figure 2) often due to mutations in 
FLNA.76,77 Single reports also associate EDS with 
polymycrogyria,78 agenesis of the corpus callosum,79 
dilatation of the 4th ventricle, supracerebellar cistern 
and lateral ventricle, or disproportional enlargement 
of anterior horn of lateral ventricle,80 but the 
consistency of such associations awaits confirmation. 
Conversely, clinical practice suggests a high rate of 
degenerative findings, in the form of generalized, 
early-onset spondylosis and disc hernias, at spine 
MRI. However, this evidence remains anecdotal81 and 
needs systematic confirmation. Spine MRI may also 
show meningeal cysts as reported in a 7-year-old girl 
with kyphoscoliotic EDS,82 in an adult with classic 
EDS83 and, with a low frequency, in JHS/EDS-HT.84 In 
EDS, meningeal (or Tarlov) cysts are apparently rare 
and very few or single. The 40-year-old woman with 
multiple and bilateral Tarlov cysts along the entire 
spine and originally defined an example of 
(unclassified) EDS by Isono et al.,85 can be best labeled 
with the diagnosis of lateral meningocele syndrome,86 
an apparently distinct form of hereditary connective 
tissue disorder with severe thecal involvement.87 The 
clinical significance of meningeal cysts is still 
unknown in EDS, although a link with orthostatic 
headache due to spontaneous cerebrospinal fluid 
leaks may be inferred,88,89 similarly as in Marfan 
syndrome. The concurrence of Chiari malformation 
(Type I) is a further apparently underreported feature 
of EDS, as to date observed in single patients only.45,46 
Nevertheless, in a surgically-oriented paper on 
hundreds of patients originally ascertained for 
symptomatic Chiari malformation, a subgroup of 
them, showing a high rate of recurrence after surgery 
and multiple features of an underlying connective 
tissue disorder, presented minor, but measurable 
neuroradiologic features of occipitoatlantoaxial 
instability: posterior gliding of the occipital condyles, 
and reduction of the clivus-axis angle, clivus-atlas 
angle, and atlas-axis angle in the upright position.90 In 
line with this, an early report describes two vascular 
EDS patients with radiologically evident atlantoaxial 
subluxation.91 Hence, investigating for cerebellar 
tonsils herniation and an occult occipitoatlantoaxial 
instability is relevant during the assessment of 
patients with occipital or postural/orthostatic 
headache, and/or additional unexplained 
neurological symptoms, such as upper limb 
paresthesias and weakness. 
Epilepsy 
The mechanisms explaining the possible association 
between EDS and seizures are likely heterogeneous. In 
1981, Cupo et al. reported a 30-year-old woman with 
EDS who died due to an intractable ventricular 
fibrillation due to myocardial infarction. She also 
presented seizures, aneurysms of the sinus of valsalva 
and severe panacinar emphysema. Necropsy finding 
included cerebral heterotopias.92 Since this early 
description, additional reports suggest the existence of 
a distinct form of EDS with cutaneous features 
resembling the classic type, coupled with 
periventricular subependymal heterotopias.76 In most 
cases, this presentation is transmitted in an X-linked 
dominant pattern and is mutated in the Filamin A.77,93 
Furthermore, Jacome reports seven EDS patients, two 
of them affected by occipital-horn disease which is 
actually moved outside the EDS classification, with 
epilepsy and various concomitant neurological 
complications.94 Of the five remaining individuals 
with more stringent diagnosis of EDS, possible 
nervous system determinants for seizures include 
basilar artery hypoplasia, hemispheric atrophy, 
venous parietal angioma, previous intracranial bleed 
and previous stroke. Additional reports of EDS with 
seizures include a 29-year-old man with unclassified 
EDS and bilateral frontocentral and frontoposterior 
polymicrogyria with hypoplasia of the cerebellar 
vermis, a 20-year-old woman with EDS-HT and 
bilateral perisylvian polymicrogyria,78 and a 16-year-
old man with classic EDS and agenesis of the corpus 
callosum.79 These reports suggest a likely increased 
rate of epilepsy in EDS. Although in many cases 
structural brain anomalies (particularly, 
periventricular heterotopias) may be identified, 
mechanisms linking seizures to a hereditary defect of 
the connective tissue remain poorly studied. 
Muscular Findings 
EDS is associated with a variety of neuromuscular 
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features, and vice versa, a variety of congenital 
myopathies display joint hypermobility and, to a 
lesser extent skin changes.95 Awareness of this clinical 
overlap between inherited connective tissue disorders 
and certain congenital myopathies might be helpful in 
recognition of these rare disorders.96 The initial 
reports of Beighton already included a high 
prevalence of myalgias and nocturnal muscle cramps 
involving the calves, especially in EDS-HT.11,97 This 
author also detected hypotonia, progressive muscle 
weakness, poorly developed musculature, and 
scapular winging, all without signs of concomitant 
myopathy. It was suggested that the muscle 
hypotonia might have a basis in the abnormality of 
the collagen in muscle sheaths rather than in the 
muscle fibers itself, but this was deemed unlikely. In 
contrast, these symptoms were considered to be 
secondary to avoidance of exercise because of the 
hypermobility and instability of joints. 
This might have contributed to the relative neglect 
of muscle features in EDS, and for years only few case 
reports pointed to these EDS manifestations. Banerjee 
et al. reported a 9-year-old boy presented with 
delayed walking and abnormal gait.98 The presence of 
marked muscle hypoplasia with hypotonia led to the 
initial diagnosis of primary muscle disease; later, he 
was found to have hyper-extensible and fragile skin 
and hyper mobile joints, and EDS was diagnosed. The 
second case was reported by Bertin et al. showing 
combination of EDS and muscular dystrophy in a 16-
year-old male patient.99 Furthermore, Palmeri et al. 
reported the association of chronic muscle pain and 
cramps and the vascular type of EDS.100 The first 
study on the physiological basis of muscle weakness 
in EDS was performed by Bilkey et al. demonstrating 
that muscle weakness was primarily due to the 
alterations in the connective tissue surrounding the 
muscle cells.101 
In 2009, Voermans et al. performed a prospective 
study in 40 genetically or biochemically confirmed 
patients with various forms of EDS (vascular EDS, 
classic EDS, EDS-HT and TNXB-deficient EDS), 
showing that mild-to-moderate neuromuscular 
involvement is common in various types of EDS.12 
Patients reported muscle weakness, myalgia, easy 
fatigability, and limited walking distance. Physical 
examination revealed mild to moderate muscle 
weakness, reduction of vibration sense, and mild 
impairment of mobility and daily activities. Ancillary 
investigations showed only mild a specific myopathic 
signs. The findings of this study have increased 
awareness of neuromuscular symptoms in EDS 
patients. Muscle biopsies to exclude the presence of a 
co-existent myopathy might not be necessary if typical 
clinical and neurophysiological findings are 
encountered and the diagnosis is confirmed by an 
expert in the field. 
Another finding in this study was the remarkable 
relation between residual TNX levels and degree of 
neuromuscular involvement, compatible with a dose-
effect relation. This points to the role of the 
extracellular matrix defect in muscle and peripheral 
nerve dysfunction in EDS12 This was confirmed in 
physiological studies in TNXB-deficient patients and 
TNXB knock-out mice.39 A recent case report on a 
patient with TNX-deficient EDS with progressive axial 
and proximal limb muscle weakness and atrophy 
further supported this. This patient had only minimal 
skin hyper extensibility, no joint abnormalities, and a 
history of easy bruising. Skeletal muscle biopsy 
disclosed striking muscle consistency and the 
abnormal presence of myotendinous junctions in the 
muscle belly.102 
Neuropathy 
Brachial and/or lumbosacral plexus neuropathies and 
compression mononeuropathies have been reported in 
several types of EDS.26,103-106 Although the study of 
Voermans et al. focused primarily on muscle, signs of 
peripheral nerve involvement in EDS were also 
observed. Nerve conduction studies demonstrated 
axonal polyneuropathy in 13% of patients, mainly of 
the vascular and TNXB-deficient types.12 Recently, a 
study on entrapment neuropathies and 
polyneuropathies in EDS-HT showed a higher 
prevalence of neuropathic symptoms 
(paresthesias/numbness in hands and/or feet) than of 
neurophysiological and ultrasound evidences of focal 
or diffuse nerve involvement. This might be due to 
presence of radiculopathy or small fiber neuropathy, 
which was not addressed in this study. Furthermore, a 
high prevalence of ulnar nerve subluxation/luxation 
at the elbow was detected on dynamic ultrasound.107 
The pathophysiological mechanism of peripheral 
neuropathy in EDS-HT seems related to the 
dislocations and subluxations due to ligament and 
capsular laxity which cause abnormal stretching of or 
pressure on peripheral nerves, and, thus can result in 
neuropathy or plexopathy. Increased vulnerability of 
peripheral nerves to stretching or pressure directly 
linked to the underlying genetic defect might also be 
involved. TNXB or Collagen I, III or V deficient epi-, 
peri- and endoneurium - the connective tissue of 
peripheral nerves might fail to resist excessive 
mechanical stress.26 
Developmental Features 
Global developmental delay evolving in intellectual 
disability is rare in EDS. Given the high frequency of 
joint laxity in the general population as well as in 
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disabling genetic conditions, the presence of a true 
global developmental delay should prompt the 
practitioner to search for different diagnoses other 
than EDS. The possible exception to this rule of thumb 
is represented by the EDS-like phenotype associated 
with 6q27 chromosome deletions,108 which may be 
detected by CGH-array, a first-line investigation for 
EDS-like subjects with intellectual disability. 
Conversely, relatively robust data support a tight link 
between joint hypermobility and reduced motor 
performance in children. In fact, while early work fails 
to detect an association between joint hypermobility 
and neurodevelopmental attributes,109 two more 
recent studies demonstrate that joint hypermobility is 
more common among children with developmental 
coordination disorders.110-112 Complementarily, 
abnormal gait, clumsiness and poor coordination are 
common findings in children with a previous 
diagnosis of JHS/EDS-HT.113,114 Such an apparently 
selective influence of congenital joint hypermobility 
on coordination could be the consequence of an 
impairment of proprioception in critical phases of 
motor development. This hypothesis lies on the 
repeated evidence of defective proprioception in 
JHS/EDS-HT.115-119 The combination of generalized 
JHM and the above-mentioned motor attributes of 
JHS/EDS-HT children explain why they perform well 
at sports, such as gymnastics, ballet and dancing, and 
often improve their motor outcome by exercise. The 
natural propensity to specific sports, which contrasts 
the poor coordination skills reported by many 
patients, is a primary feature of the “first phase” of 
disease progression recently outlined for JHS/EDS-
HT.14,35,46 This neurodevelopmental profile seems 
extremely common in JHS/EDS-HT and, presumably, 
in other hereditary connective tissue disorders. 
Conclusion 
This overview on neurological manifestations of EDS 
demonstrates a largely unrecognized set of central 
and peripheral nervous system features in patients 
with heritable connective tissue disorders. The 
familiarity that any neurologist has with some of these 
manifestations when reported in the general 
population, such as cerebrovascular disease, 
headache, myalgia and fatigue, poses neurologists in a 
privileged position for promptly recognizing EDS. 
Although the global assessment of EDS patients is, by 
definition, multisystem and often managed by other 
specialists, such as rheumatologists and clinical 
geneticists, the neurologist has a high chance of 
evaluating still undetected EDS patients with a 
neurological presentation. In addition, while the 
pathognomonic features of EDS are not historical 
heritages of neurology, now, we know that a great 
proportion of the increased mortality and morbidity 
of EDS patients is linked to the reverberations that a 
primary connective tissue derangement has on 
nervous system development and functions. Hence, 
all practitioners occasionally or constantly involved in 
the management of EDS should be better aware of the 
neurological manifestations of this condition on both 
clinical and research perspectives. 
 
 
Figure 2. Periventricular heterotopias in a 37-year-old woman with features of classic Ehlers-Danlos syndrome 
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On a practical point of view, the group of EDS 
types is large with a wide spectrum of manifestations 
and possible complications. Nevertheless, in this 
paper reviewing neurological features in EDS, the 
variability at presentation may be narrowed to a 
discrete list (Table 4).120 Figure 3120 illustrates the 
procedures for assessing generalized JHM by the 
Beighton score121 which is currently included in both 
Villefranche and Brighton criteria, as well as the 
alternative Bulbena score, which has proved to be 
equally efficient in discriminating hypermobile and 
non-hypermobile subjects.122 Both sets have limits and 
are not ideal in all situations, but may be considered 
useful first-line screening methods. A positive scoring 
as illustrated in figure 3 should prompt the clinical 
neurologist to refer the patient to an expert in the field 
for diagnosis confirmation and appropriate 
multidisciplinary management. 
 
Table 4. “Red flags” for suspecting Ehlers-Danlos syndromes 
Key clinical clues by category 
General history Delayed gross motor milestones 
Developmental coordination disorder 
Double-jointed in sports; being proficient at ballet and gymnastics during childhood 
Showing hypermobility “tricks” during childhood 
Giving up sports during the teens due to recurrent injuries, pain, and fatigue 
Mild generalized muscle weakness 
Unexplained musculoskeletal pain 
Easy fatigability 
Paresthesias 
Medical history Recurrent (sub)luxations 
Tendon and muscle rupture 
Anal prolapse in childhood 
Reduced effect of local anesthesia 
Complications of surgery 
Easy bruising, sometimes with incorrect suspicion of child abuse 
Abnormal wound healing with wide atrophic scars 
Uterus prolapse or cervical insufficiency with premature delivery 
Early onset varicose veins 
Pneumothorax or pneumohematothorax 
Spontaneous arterial rupture (mostly vascular or kyphoscoliotic type) 
Clubfoot (mostly vascular type) 
Intestinal or uterine fragility or rupture (mostly vascular type) 
Severe scoliosis at birth (mostly kyphoscoliotic type) 
Congenital bilateral hip dislocation (mostly arthrochalasia type) 
Family history Generalized hypermobility/contortionism 
Sudden death (vascular type) 
Physical 
examination 
Generalized joint hypermobility (Beighton score of 5 or more) 
Increased skin hyperextensibility ( ≥ 3 cm on volar side of lower arm) Smooth, velvety skin 
Wide, atrophic scars 
Molluscoid pseudotumors 
Subcutaneous feroids 
Thin, translucent skin, characteristic facial appearance, and acrogeria (vascular type) 
Gingival recessions/(early onset) parodontopathy 
Microcornea (kyphoscoliotic type) 
Congenital kyphoscoliosis (kyphoscoliotic or arthrochalasia type) 
Neurological 
examination 
Mild proximal weakness (MRC 4) 
Mild reduction of vibration sense (measured with Rydell-Seiffer tuning fork) 
Reduction but no absence of tendon reflexes 
Ancillary 
investigations 
Nerve conduction studies: reduction of CMAP of distal muscles, mild axonal sensomotor 
polyneuropathy 
Electromyography: mixed pattern of both small (myopathic) and larger (neurogenic) units, or 
predominantly myopathic units 
CK: normal or mildly elevated (generally < 500) 
Muscle biopsy: normal or mild myopathic features (increase of fibre diameter variance and internal nuclei) 
Heart imaging: mitral valve prolapse, or proximal, non-progressive aortic dilatation  
Bone computer mineralometry: early onset osteopenia 
Adapted from Voermans, CMAP: Compound muscle action potential, EDS: Ehlers-Danlos syndrome 
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Figure 3. Summary of the Beighton and Bulbena scores for assessing joint hypermobility. The picture of the 
Beighton score is freely available at: http://www.hypermobility.org/beighton.php 
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